BridgeBio Pharma, Inc. (BBIO)

SEC filing

BridgeBio Pharma, Inc.

BBIO · CIK 1743881

4 · Nov 14, 2025 · Valantine Hannah sold 25.48K shares at $66.07/share ($1.7M); exercised options for 25.48K shares

Valantine Hannah sold 25.48K shares at $66.07/share ($1.7M); exercised options for 25.48K shares

FORM 4

xslF345X05/wk-form4_1763157038.xmlSEC.gov

hannahvalentine.htm

hannahvalentine.htmSEC.gov

Graphics and non-inline formats (not embedded below).